The company is developing new biological entities (NBEs) focusing on antibody-drug conjugates and antibody-based therapeutics ...
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced the publication in Science Immunology of preclinical data demonstrating the potential of IPH6501, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback